Price
No data yet.
Social Signal Score
Revenue
$6.39M+1423.43%Company Profile
- CEO
- Elazar Sonnenschein
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 71
- Beta
- 0.40
- Country
- IL
- Piotroski score
- 4 / 9 (Middling)
- Altman Z-score
- -3.82
Financials
PLSM has only 11 quarterly periods on file — the charts below show the full history available.
Revenue
$6.39M+1423.4%Net Income
$-36.85MEBITDA
$-20.21MFree Cash Flow
$-17.25MEPS (diluted)
$-5.66Shares Outstanding (diluted)
6.50M+13.5%Operating Expenses
$24.15MCash & Debt
$70.26MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $40.02M | $-15.85M | $-2.47 |
| 2024 | $9.64M | $-36.65M | $-5.71 |
| 2023 | $6.14M | $-58.07M | $-9.07 |
| 2022 | $10.59M | $-21.66M | $-3.58 |
| 2021 | $1.58M | $-25.61M | $-5.00 |
| 2020 | $0.00 | $-13.75M | $-2.22 |
| 2019 | $0.00 | $-4.64M | $-0.77 |
Valuation
PLSMhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
100-16.67%Social Signal Score
Mentions (4)
- Newsprnewswire.com·19d ago·Neutral
Pulsenmore Expands Its Fertility Platform into the UK MHRA registration allows Pulsenmore FC to be marketed across the United Kingdom and Northern Ireland, extending the Company's home ultrasound platform into the UK fertility market where more than 100,000 IVF and fertility treatment cycles were performed in 2024. OMER, Israel, Sept.
View source ↗ - Newsprnewswire.com·36d ago·Neutral
…26 Management to Host Webcast today at 8:30 am ET to discuss Results and Provide Business Update OMER, Israel, Aug. 31, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a leading innovator in remote maternal-fetal healthcare and home ultrasound solutions, presents the key operational, commercial, regulatory, and technological achievements as well as financial updates for the six month period ended June 30, 2026.
View source ↗ - Newsprnewswire.com·43d ago·Neutral
Pulsenmore Ltd. To Announce Financial Results and Business Highlights and Hold Conference Call for the First Half of 2026 OMER, Israel, Aug. 24, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a leading innovator in remote maternal-fetal healthcare and home ultrasound solutions, today announces that it will release its financial results and business highlights for the six months ended June 30, 2026 on August 31, 2026 at 8:30 am ET.
View source ↗ - Newsprnewswire.com·48d ago·Positive
…v, expanding the ability to incorporate at-home ultrasound scans as part of pregnancy monitoring RAMAT GAN, Israel, Aug. 19, 2026 /PRNewswire/ -- Pulsenmore (NASDAQ: PLSM) (TASE: PLSM), a developer of home ultrasound solutions supported by remote medical guidance, today announced the expansion of its activities in Israel. The Company's home ultrasound technology will be integrated at the Lis Maternity and Women's Hospital at Ichilov, a major center for women's and maternity care in Israel, joini…
View source ↗
Insider trading
Open-market buys and sells by PLSM officers and directors.
No open-market trades in the recent filings. All 12 recent Form 4 entries were share awards, option exercises or tax withholding — pay, not decisions to buy or sell.
12 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in PLSM.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.